Partnering for Progress: Exploring Biotech Innovations and Opportunities in Saudi Arabia
June 17, 2025 | BIO International Convention | Boston, MA
Saudi Arabia is building a globally competitive biotech ecosystem – driven by agile regulation, world-class institutions, and data-powered innovation. This high-level Super Session brings together the Kingdom’s top healthcare, research, and investment leaders to showcase how Saudi Arabia is translating strategy into real-world impact – and why now is the moment to partner.
From clinical trials to advanced therapeutics, from digital health infrastructure to sovereign manufacturing, the session explores how Saudi Arabia is aligning national assets to lead in biotech.
Key Themes:
Cohesive and Enabling Ecosystem
Agile regulation & global harmonization
Clinical trial growth and real-world data enablement
Extensive and robust digital platform
Biomanufacturing and strategic investment
National R&D orchestration and talent development
Open invitation for global partnerships
Speakers:
H.E. Dr. Hisham Al-Jadhey – CEO, Saudi Food and Drug Authority (SFDA)
H.E. Dr. Bandar Al Knawy – CEO, King Abdullah International Medical Research Center (KAIMRC)
H.E. Dr. Majid Al Fayyadh – CEO, King Faisal Specialist Hospital & Research Centre (KFSH&RC)
Mr. Raid Ismail – Head of MENA Direct Investments, Public Investment Fund (PIF)
Prof. Faris Alanzi – CEO, Saudi National Institute of Health (SNIH)